NCT07622849Enrolling By Invitation不适用
FMT in Transplant-related Gastrointestinal Mucositis Treatment
The First Affiliated Hospital of Soochow University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年3月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 20
- 试验地点
- 1
研究概览
简要总结
With the stem cell transplant increasing, patients which effected with transplant-related gastrointestinal mucositis (TRGM) have also increased. To evaluate the safety and efficacy of FMT for TRGM, patients with TRGM were recruited.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Transplant-related gastrointestinal mucositis
排除标准
- •age>65; or age<15;
研究者
Qi Xiao-Fei
professor
The First Affiliated Hospital of Soochow University
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy2024-512969-14-01CHU Gabriel-Montpied165
尚未招募
2 期
Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLCNCT07432984Se-Hoon Lee15
尚未招募
2/3 期
Improving Gut Health: Using Faecal Microbiota Transplantation (FMT) to Treat Digestive and Mental Health in Functional Bowel Disorder(FBD) PatientsCTRI/2024/06/069390Dr Jayeeta Bhowmick120
尚未招募
不适用
Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot StudyCoronary Artery DiseaseNCT07421947University of Zurich30
招募中
2 期
Fecal Microbiota Transplantation to RESCUE patients with unresectable Hcc progressors to first line therapy with AtezolizUmaB and Bevacizumab (RESCUE-HUB)2023-510504-45-00Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico15